Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates

Bedaquiline Drug Resistance Emergence Assessment in Multidrug-resistant tuberculosis (MDR-TB) (DREAM) was a 5-year (2015 to 2019) phenotypic drug resistance surveillance study across 11 countries. DREAM assessed the susceptibility of 5,036 MDR-TB isolates of bedaquiline treatment-naive patients to b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaniga, Koné, Hasan, Rumina, Jou, Ruwen, Vasiliauskienė, Edita, Chuchottaworn, Charoen, Ismail, Nazir, Metchock, Beverly, Miliauskas, Skaidrius, Viet Nhung, Nguyen, Rodrigues, Camilla, Shin, Soyoun, Simsek, Hulya, Smithtikarn, Saijai, Ngoc, Anh Le Thi, Boonyasopun, Jirakan, Kazi, Mubin, Kim, Seungmo, Kamolwat, Phalin, Musteikiene, Greta, Sacopon, Catherine Ann, Tahseen, Sabira, Vasiliauskaitė, Laima, Wu, Mei-Hua, Vally Omar, Shaheed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Mycobacteriology and Aerobic Actinomycetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769720/
https://www.ncbi.nlm.nih.gov/pubmed/34705538
http://dx.doi.org/10.1128/JCM.02919-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769720/
https://www.ncbi.nlm.nih.gov/pubmed/34705538
http://dx.doi.org/10.1128/JCM.02919-20

Ejemplares similares